ArticleCell communication and signaling : CCS2026
STING-STAT1-ZBP1 axis orchestrates PANoptotic signaling in ischemia-reperfusion induced acute kidney injury.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in PANoptosis research in kidney disease: mechanistic networks, pathological roles, and potential intervention strategies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ischemia-reperfusion induced acute kidney injury (IRI-AKI) progression involves dysregulated tubular cell death. Z-DNA-binding protein 1 (ZBP1) mediated PANoptosis is a newly discovered form of programmed cell death; however, its role and upstream regulation in IRI-AKI remain unclear. Both ZBP1 and stimulator of interferon genes (STING) are cytosolic innate immune sensors that not only mediate antiviral immunity but also play critical roles in sterile inflammation. Here, our results indicate that inhibition of STING protects against IRI-AKI through downregulation of ZBP1 activity. Mechanistically, STING activation promotes the nuclear translocation of signal transducer and activator of transcription 1 (STAT1), which directly binds to the ZBP1 promoter to upregulate its transcription. Additionally, interferon signaling and STING cooperatively promotes STAT1 activation, thereby aggravating ZBP1 mediated PANoptosis. These findings establish the STING–STAT1–ZBP1 axis as a critical pathogenic hub and highlight it as a promising therapeutic target for IRI-AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.